12 Small Cap Stocks with High Upside Potential

Page 11 of 11

1. Mineralys Therapeutics, Inc. (NASDAQ:MLYS)

Market Capitalization: $893.55 Million

Analyst Upside: 206.35%

No. of Hedge Fund Investors: 36

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) is one of the 12 Small Cap Stocks with High Upside Potential. On June 17, Mineralys Therapeutics, Inc. (NASDAQ:MLYS) reported positive topline data from its Phase 2 Explore-CKD trial of lorundrostat.

The company achieved positive topline data for the ongoing trials of lorundrostat for the treatment of subjects with hypertension and comorbid CKD. The crossover trial met the primary endpoint and showed clinically meaningful reductions in both systolic automated office blood pressure (AOBP) and urine albumin-to-creatinine ratio (UACR). The 25 mg dosage of lorundrostat achieved a 9.3 mmHg reduction in AOBP and a 7.5 mmHg placebo-adjusted reduction at four weeks. Whereas, lorundrostat showed a reduction in pre-defined endpoint spot urine UACR of 31%.

“Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population. Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission,” stated Jon Congleton, Chief Executive Officer of Mineralys.

The company continues to enroll subjects with OSA and uncontrolled hypertension for its ongoing Explore-OSA trials.

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) is a clinical-stage biopharmaceutical company that develops medicines to target diseases driven by dysregulated aldosterone in the U.S.

While we acknowledge the potential of MLYS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MLYS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11